The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global NGS Tumor Gene Analysis Software Market Research Report 2024

Global NGS Tumor Gene Analysis Software Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1765153

No of Pages : 89

Ask Your Query

Synopsis
NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.

Global NGS Tumor Gene Analysis Software market is projected to reach US$ 4644.9 million in 2029, increasing from US$ 1509 million in 2022, with the CAGR of 17.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NGS Tumor Gene Analysis Software market research.

Key companies engaged in the NGS Tumor Gene Analysis Software industry include Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine and GTH.O, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of NGS Tumor Gene Analysis Software were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole NGS Tumor Gene Analysis Software market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global NGS Tumor Gene Analysis Software market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Roche
  • Illumina
  • Thermo Fisher Scientific
  • BGI Group
  • Novogene
  • Geneseeq
  • AmoyDx
  • Burning Rock Medicine
  • GTH.O
  • Golden Helix, Inc
  • Diatech Pharmacogenetics
  • ViennaLab Diagnostics GmbH
  • 3D Medicines

Segment by Type

  • Non-Small Cell Lung Cancer
  • Human 6 Gene Mutations
  • Human 12 Gene Mutations
  • Other

Segment by Application

  • Hospitals and Health Systems
  • Research Institute
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The NGS Tumor Gene Analysis Software report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Non-Small Cell Lung Cancer
1.2.3 Human 6 Gene Mutations
1.2.4 Human 12 Gene Mutations
1.2.5 Other
1.3 Market by Application
1.3.1 Global NGS Tumor Gene Analysis Software Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Health Systems
1.3.3 Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS Tumor Gene Analysis Software Market Perspective (2018-2029)
2.2 NGS Tumor Gene Analysis Software Growth Trends by Region
2.2.1 Global NGS Tumor Gene Analysis Software Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 NGS Tumor Gene Analysis Software Historic Market Size by Region (2018-2023)
2.2.3 NGS Tumor Gene Analysis Software Forecasted Market Size by Region (2024-2029)
2.3 NGS Tumor Gene Analysis Software Market Dynamics
2.3.1 NGS Tumor Gene Analysis Software Industry Trends
2.3.2 NGS Tumor Gene Analysis Software Market Drivers
2.3.3 NGS Tumor Gene Analysis Software Market Challenges
2.3.4 NGS Tumor Gene Analysis Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS Tumor Gene Analysis Software Players by Revenue
3.1.1 Global Top NGS Tumor Gene Analysis Software Players by Revenue (2018-2023)
3.1.2 Global NGS Tumor Gene Analysis Software Revenue Market Share by Players (2018-2023)
3.2 Global NGS Tumor Gene Analysis Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS Tumor Gene Analysis Software Revenue
3.4 Global NGS Tumor Gene Analysis Software Market Concentration Ratio
3.4.1 Global NGS Tumor Gene Analysis Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS Tumor Gene Analysis Software Revenue in 2022
3.5 NGS Tumor Gene Analysis Software Key Players Head office and Area Served
3.6 Key Players NGS Tumor Gene Analysis Software Product Solution and Service
3.7 Date of Enter into NGS Tumor Gene Analysis Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS Tumor Gene Analysis Software Breakdown Data by Type
4.1 Global NGS Tumor Gene Analysis Software Historic Market Size by Type (2018-2023)
4.2 Global NGS Tumor Gene Analysis Software Forecasted Market Size by Type (2024-2029)
5 NGS Tumor Gene Analysis Software Breakdown Data by Application
5.1 Global NGS Tumor Gene Analysis Software Historic Market Size by Application (2018-2023)
5.2 Global NGS Tumor Gene Analysis Software Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America NGS Tumor Gene Analysis Software Market Size (2018-2029)
6.2 North America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America NGS Tumor Gene Analysis Software Market Size by Country (2018-2023)
6.4 North America NGS Tumor Gene Analysis Software Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS Tumor Gene Analysis Software Market Size (2018-2029)
7.2 Europe NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe NGS Tumor Gene Analysis Software Market Size by Country (2018-2023)
7.4 Europe NGS Tumor Gene Analysis Software Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS Tumor Gene Analysis Software Market Size (2018-2029)
8.2 Asia-Pacific NGS Tumor Gene Analysis Software Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2018-2023)
8.4 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS Tumor Gene Analysis Software Market Size (2018-2029)
9.2 Latin America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America NGS Tumor Gene Analysis Software Market Size by Country (2018-2023)
9.4 Latin America NGS Tumor Gene Analysis Software Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS Tumor Gene Analysis Software Market Size (2018-2029)
10.2 Middle East & Africa NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2018-2023)
10.4 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche NGS Tumor Gene Analysis Software Introduction
11.1.4 Roche Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina NGS Tumor Gene Analysis Software Introduction
11.2.4 Illumina Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Introduction
11.3.4 Thermo Fisher Scientific Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 BGI Group
11.4.1 BGI Group Company Detail
11.4.2 BGI Group Business Overview
11.4.3 BGI Group NGS Tumor Gene Analysis Software Introduction
11.4.4 BGI Group Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.4.5 BGI Group Recent Development
11.5 Novogene
11.5.1 Novogene Company Detail
11.5.2 Novogene Business Overview
11.5.3 Novogene NGS Tumor Gene Analysis Software Introduction
11.5.4 Novogene Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.5.5 Novogene Recent Development
11.6 Geneseeq
11.6.1 Geneseeq Company Detail
11.6.2 Geneseeq Business Overview
11.6.3 Geneseeq NGS Tumor Gene Analysis Software Introduction
11.6.4 Geneseeq Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.6.5 Geneseeq Recent Development
11.7 AmoyDx
11.7.1 AmoyDx Company Detail
11.7.2 AmoyDx Business Overview
11.7.3 AmoyDx NGS Tumor Gene Analysis Software Introduction
11.7.4 AmoyDx Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.7.5 AmoyDx Recent Development
11.8 Burning Rock Medicine
11.8.1 Burning Rock Medicine Company Detail
11.8.2 Burning Rock Medicine Business Overview
11.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Introduction
11.8.4 Burning Rock Medicine Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.8.5 Burning Rock Medicine Recent Development
11.9 GTH.O
11.9.1 GTH.O Company Detail
11.9.2 GTH.O Business Overview
11.9.3 GTH.O NGS Tumor Gene Analysis Software Introduction
11.9.4 GTH.O Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.9.5 GTH.O Recent Development
11.10 Golden Helix, Inc
11.10.1 Golden Helix, Inc Company Detail
11.10.2 Golden Helix, Inc Business Overview
11.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Introduction
11.10.4 Golden Helix, Inc Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.10.5 Golden Helix, Inc Recent Development
11.11 Diatech Pharmacogenetics
11.11.1 Diatech Pharmacogenetics Company Detail
11.11.2 Diatech Pharmacogenetics Business Overview
11.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Introduction
11.11.4 Diatech Pharmacogenetics Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.11.5 Diatech Pharmacogenetics Recent Development
11.12 ViennaLab Diagnostics GmbH
11.12.1 ViennaLab Diagnostics GmbH Company Detail
11.12.2 ViennaLab Diagnostics GmbH Business Overview
11.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Introduction
11.12.4 ViennaLab Diagnostics GmbH Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.12.5 ViennaLab Diagnostics GmbH Recent Development
11.13 3D Medicines
11.13.1 3D Medicines Company Detail
11.13.2 3D Medicines Business Overview
11.13.3 3D Medicines NGS Tumor Gene Analysis Software Introduction
11.13.4 3D Medicines Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)
11.13.5 3D Medicines Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock